ArticleFrontiers in cardiovascular medicine2025
Association and impact of inflammatory markers and cardiac structure on atrial fibrillation risk: a study integrating NHANES with real-world data.
Article in Frontiers in cardiovascular medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Inflammation plays a central role in the pathogenesis of atrial fibrillation (AF), a common cardiac arrhythmia. Complete blood count (CBC)-derived markers of inflammation, including the systemic inflammatory index (SII) and systemic inflammatory response index (SIRI), have emerged as novel biomarkers of systemic inflammation. Although small prior studies have reported associations between certain inflammatory markers and AF, their limited sample sizes and potential baseline imbalances prevent definitive conclusions. Using a large population-based cohort, this study examines the association between CBC-derived inflammatory markers-SIRI, SII, monocyte-to-lymphocyte ratio (MLR), aggregate index of systemic inflammation (AISI), neutrophil-monocyte-to-lymphocyte ratio (NMLR), neutrophil-to-lymphocyte ratio (NLR), and platelet-to-lymphocyte ratio (PLR)-and the risk of AF, and investigates potential mediating mechanisms by integrating clinical data. Methods: This cross-sectional analysis included 10,474 adults aged ≥20 years from the National Health and Nutrition Examination Survey (NHANES) 2013-2020 and was validated in 13,707 adults aged ≥20 years from Zibo Central Hospital 2015-2024. Seven inflammatory markers were derived from CBC data and categorized into low, medium, and high quartiles according to their distributions. A weighted multivariable logistic regression adjusted for confounders, including age, sex, hypertension, and diabetes. Associations between inflammatory markers and atrial fibrillation were expressed as odds ratios (OR) with 95% confidence intervals (CI). Restricted cubic spline (RCS) regression assessed nonlinear relationships. Subgroup and interaction analyses evaluated the influence of demographic and clinical factors. Finally, a mediation model examined the mediating role of left atrial diameter. Results: Of the 10,474 participants in the NHANES database, 136 (1.3%) were diagnosed with AF. After full adjustment, the highest SIRI tertile showed a significantly increased risk of AF compared with the lowest tertile (OR = 2.182; 95% CI: 1.094-4.354; Conclusion: This study suggests that elevated SIRI may represent a potential biomarker and is associated with an increased risk of AF, and found that left atrial diameter may partially mediate this relationship, suggesting SIRI as a potential inflammatory biomarker for AF prediction. Although other CBC-derived markers did not show significant associations, the results underscore inflammation's role in AF pathogenesis. Further longitudinal studies are needed to validate these findings and clarify the underlying mechanisms.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.